Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Thrombosis
Pharma
Mylan lays out $756M for EU rights to Aspen thrombosis meds
Mylan will lay out $756 million to acquire the EU rights to a suite of Aspen's sterile injectable anticoagulants in a portfolio-boosting move.
Kyle Blankenship
Sep 8, 2020 10:07am
AHA: J&J, Bayer still seeking answers in aborted Xarelto study
Nov 16, 2019 5:45pm
Boehringer balks as India clears Gennova's tenecteplase for stroke
Aug 19, 2016 10:37am
